TECON(SZ:002100)2022-12-07 09:10Group 1: Company Overview - Xinjiang Tiankang Animal Husbandry Biotechnology Co., Ltd. is involved in a major asset restructuring, currently in the process of merging with Tiankang Holding Group [1]. - The company has received approval from the China Securities Regulatory Commission for the asset transfer related to the merger [1]. Group 2: Impact of Market Conditions - Recent fluctuations in pig prices have positively influenced the company's performance in the first half of the year, with national pig prices currently on the rise [2]. - The company anticipates that its pig farming capacity could reach 500,000 heads following the merger [2]. Group 3: Business Development - Post-merger, the company will establish a full industry chain structure encompassing animal vaccines, feed, plant protein, breeding, pig farming, slaughter processing, and meat product sales [2]. - The animal vaccine business experienced significant growth in 2014, with stable government procurement and ongoing efforts to enhance market-driven sales [2].